GlassScriptPhysician profile
Timothy J Elfelt
NPI 1780754168
$920.38
in general payments reported to CMS, 2019-2025
16 companies · $187 in 2025
The $187 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $74.88 · 2021: $19.04 · 2022: $50.71 · 2023: $388 · 2024: $96.09 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $561 · Debt Forgiveness: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $561.28 |
| Debt Forgiveness | $109.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Women'S Health, INC. | $341.40 | 2023 | Myrisk |
| Baxter Healthcare | $109.23 | 2025 | |
| Intuitive Surgical, INC. | $105.24 | 2019 | |
| Abbvie INC. | $77.42 | 2020-2025 | |
| Abbott Laboratories | $40.57 | 2024 | Freestyle Libre 3 |
| Meditrina | $32.84 | 2022 | |
| Astellas Pharma US INC | $31.96 | 2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $24.33 | 2023 | |
| Eisai INC. | $23.79 | 2020 | |
| Glaxosmithkline, LLC. | $23.56 | 2024 | Arexvy |
| Aspira Women'S Health INC | $22.12 | 2023 | Ova1 |
| Astrazeneca Pharmaceuticals LP | $21.21 | 2025 | Breztri |
| Hologic Sales and Service, LLC | $19.04 | 2021 | |
| Evofem Biosciences, INC. | $17.87 | 2022 | |
| Coopersurgical, INC. | $14.97 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $14.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Elfelt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.